RFT - supply of aripiprazole, celecoxib, etoricoxib and prednisolone
Pharmac invites tenders for the supply of medicines to DHB hospitals and to community pharmacies in New Zealand.
Pharmac invites proposals for the supply of aripiprazole tablets, Cox-2 Inhibitors (celecoxib and etoricoxib) and prednisolone tablets in New Zealand.
This request for tender (RFT) document incorporates the following schedules:
- Schedule 1 sets out the definitions used in this RFT;
- Schedule 2 specifies the Tender Items for which you may submit a Tender Bid in relation to community supply and hospital supply and provides background information regarding this RFT;
- Schedule 3 describes the process Pharmac intends to follow in relation to this RFT, and provides instructions on how to submit a Tender Bid in relation to community supply and hospital supply;
- Schedule 4 sets out the terms that will apply if your Tender Bid in relation to community and hospital supply is awarded Principal Supply Status;
- Schedule 5 sets out the additional terms that will apply if your Tender Bid in relation to community supply is awarded Principal Supply Status;
- Schedule 6 sets out the additional terms that will apply if your Tender Bid in relation to hospital supply is awarded Principal Supply Status.
Full text of RFT - supply of aripiprazole, celecoxib, etoricoxib and prednisolone [PDF, 311 KB]
If you wish to submit a proposal, you must submit it to PHARMAC via the Government Electronic Tenders Service (GETS) (www.gets.govt.nz(external link)) no later than 4pm NZT Tuesday 23 November 2021 - RFx ID 24983911.
We encourage suppliers to register with GETS and subscribe to this RFP. If you have any questions about this RFP, please post these on GETS (www.gets.govt.nz(external link)). We will be accepting questions until 5pm NZT Tuesday 9 November 2021.
We look forward to receiving your tender.